帕金森病的基因治疗：我们找到治愈方法了吗？ - Suppr

Gene therapy for Parkinson's disease: do we have the cure?

作者信息

Benabid Alim Louis

机构信息

CEA Minatec LETI, 38054 Grenoble, France.

出版信息

Lancet Neurol. 2010 Dec;9(12):1142-1143. doi: 10.1016/S1474-4422(10)70256-8.

DOI:10.1016/S1474-4422(10)70256-8

PMID:21087733

Abstract

摘要

相似文献

Gene therapy for Parkinson's disease: do we have the cure?

Lancet Neurol. 2010 Dec;9(12):1142-1143. doi: 10.1016/S1474-4422(10)70256-8.

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.

Lancet Neurol. 2010 Dec;9(12):1164-1172. doi: 10.1016/S1474-4422(10)70254-4. Epub 2010 Oct 20.

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.

Lancet Neurol. 2008 May;7(5):400-8. doi: 10.1016/S1474-4422(08)70065-6. Epub 2008 Apr 2.

Parkinson's disease, primates, and gene therapy: vive la différence?

Mov Disord. 2011 Jan;26(1):2-3. doi: 10.1002/mds.23544. Epub 2010 Dec 17.

AAV2-Neurturin for Parkinson's Disease: What Lessons Have We Learned?

Methods Mol Biol. 2016;1382:485-90. doi: 10.1007/978-1-4939-3271-9_32.

Long-Term Safety of Patients with Parkinson's Disease Receiving rAAV2-Neurturin (CERE-120) Gene Transfer.

Hum Gene Ther. 2016 Jul;27(7):522-7. doi: 10.1089/hum.2015.134. Epub 2016 Feb 24.

Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating "clinical proof-of-concept" for AAV-neurturin (CERE-120) in Parkinson's disease.

Neurobiol Aging. 2013 Jan;34(1):35-61. doi: 10.1016/j.neurobiolaging.2012.07.018. Epub 2012 Aug 24.

[Advances in the application of gene therapy for Parkinson's disease with adeno-associated virus].

Yao Xue Xue Bao. 2014 May;49(5):576-81.

Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.

Ann Neurol. 2015 Aug;78(2):248-57. doi: 10.1002/ana.24436. Epub 2015 Jun 10.

Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease.

Mol Ther. 2007 Jan;15(1):62-8. doi: 10.1038/sj.mt.6300010.

引用本文的文献

Association of MTHFR C677T with total homocysteine plasma levels and susceptibility to Parkinson's disease: a meta-analysis.

Neurol Sci. 2015 Jun;36(6):945-51. doi: 10.1007/s10072-014-2052-6. Epub 2015 Jan 7.

The degenerating substantia nigra as a susceptible region for gene transfer-mediated inflammation.

Parkinsons Dis. 2011;2011:931572. doi: 10.4061/2011/931572. Epub 2011 May 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Gene therapy for Parkinson's disease: do we have the cure?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献